OncologyEducation invites you to attend The Best of Hematology Summit Canada 2021. This exclusive event, co-chaired by Dr. Martina Trinkaus and Dr. Matthew Seftel, will present a summary of the most significant treatment advances in hematological malignancies presented at major international events in 2020.
• To discuss the pivotal hematology trials published or presented in 2020
• To review the current standard of care for non-malignant and malignant hematological conditions
• To discuss the current controversies in the management of hematologic disorders
• To discuss the management of hematological conditions during the COVID-19 pandemic
Registration will be complimentary for Healthcare professionals. Industry representatives (both sponsor and non-sponsor) can register by contacting Laura Davidson at laura@oncologyeducation.com
Dr. Martina Trinkaus
Dr. Martina Trinkaus is an assistant professor and staff hematologist at St. Michael's Hospital with the University of Toronto. She completed her undergraduate training in Life Sciences and Physical Health and Education at Queen's University and completed both her medical school and residency training at the University of Toronto. Since graduating from the Hematology training program in Toronto in 2009, she has remained at St. Michael's Hospital practicing malignant hematology and serving on much education-based committees. She currently is the program director for the Adult Hematology Training Program and coordinates the hematology curriculum at St. Michael's. Her medical interests include medical education with research focused on mentorship and e-based learning.
Dr. Matthew Seftel
Dr. Matthew Seftel is a Hematologist based at BC Cancer/Vancouver General Hospital, where he is a clinical professor at the University of British Columbia. His clinical, teaching, and research interests are in complex hematological malignancies and Blood and Marrow Transplant/cellular therapy.
For more information, please send requests to Laura Davidson laura@oncologyeducation.com.
For sponsorship-related inquiries, please contact Bernadette Gregoris, Director of Operations at bernadette@oncologyeducation.com.
Platinum Sponsors |
||
|---|---|---|
 |
|
 |
 |
|
|
Gold Sponsors |
||
|
|
||
Silver Sponsors |
||
|
|
|
|
|
|
|
|
|
|
||
| 11:00 a.m. - 11:15 a.m. EST | Welcome Address by Chairs - Dr. Martina Trinkaus and Dr. Matthew Seftel |
| 11:15 a.m. - 12:00 p.m. EST | Janssen Breakfast Symposium: Evolving Treatment Paradigms for Newly Diagnosed Patients with Multiple Myeloma to Improve Long-Term Outcomes - Dr. Joseph Mikhael |
| 12:00 p.m. - 12:20 p.m. EST | Multiple Myeloma - Dr. Keith Stewart |
| 12:20 p.m. - 12:30 p.m. EST | Morning Break |
| 12:30 p.m. - 12:50 p.m. EST | COVID-19 and Thrombosis - Dr. Deborah Siegal |
| 12:50 p.m. - 1:10 p.m. EST | COVID-19 and Plasma/Blood Transfusion - Dr. Jeannie Callum |
| 1:10 p.m. - 1:20 p.m. EST | Q&A from Morning Session |
| 1:20 p.m. - 1:50 p.m. EST | Lunch Break |
| 1:50 p.m. - 2:35 p.m. EST | BMS Lunch Symposium: Evolution of Post-Remission Clinical Strategies in AML: Mission Possible - Dr. Lynn Savoie |
| 2:35 p.m. - 2:55 p.m. EST | Chronic Lymphocytic Leukemia - Dr. Caroline Owen |
| 2:55 p.m. - 3:15 p.m. EST | Lymphoma - Dr. Laurie Sehn |
| 3:15 p.m. - 3:25 p.m. EST | Afternoon Break |
| 3:25 p.m. - 4:10 p.m. EST | Novartis Symposium: ASH 2020 CML Update: Improving Outcomes for Advanced Patients - Dr. Sarit Assouline |
| 4:10 p.m. - 4:30 p.m. EST | Acute Myeloid Leukemia - Dr. David Sanford |
| 4:30 p.m. - 4:50 p.m. EST | Acute Lymphoblastic Leukemia & CAR T-cell Therapy - Dr. Andre Schuh |
| 4:50 p.m. - 5:00 p.m. EST | Q&A from Afternoon Session |
| 5:00 p.m. - 5:10 p.m. EST | Closing Remarks by Chairs - Dr. Martina Trinkaus and Dr. Matthew Seftel |
